Pharnext Announces R&D Agreement with Galapagos to Generate a New Pipeline of Drug Combinations

Pharnext SA , biopharmaceutical co. developing an advanced portfolio of products in the field of neurodegenerative diseases announced a research and development agreement with Galapagos NV.

CordenPharma Wins 2017 Life Science Leader CMO Leadership Awards Across All Award Categories

CordenPharma, a full-service Contract Development & Manufacturing Organization , will be awarded 2017 CMO Leadership Awards presented by Life Science Leader magazine...

LANXESS participates in PU Tech 2017, March 8-10, 2017 in Delhi

LANXESS, the global specialty chemicals company, is showcasingits wide-ranging product portfolio which meets virtually all the polyurethaneindustry’s requirements,at PU Tech 2017 being held during 08 to 10 March 2017, at the India Expo Center.

INCJ, Takeda, and Medical holdings Partner to Launch a Biotech Venture

Innovation Network Corporation of Japan Takeda Pharmaceutical Company Limited , and Medical holding corp have agreed to jointly invest a total of 10 billion yen to establish a new company, which will be named Scohia Pharma Inc.

Charles River Laboratories and Chiesi Farmaceutici announce Extension of Integrated Respiratory Drug Discovery Program.

Charles River Laboratories International Inc. , a leading early-stage contract research organization announced that it has extended its longstanding, strategic, integrated drug discovery partnership...

Ferring acquires ex-U.S. assets and rights for Vitaros , Apricus on demand topical cream for erectile dysfunction

Ferring Pharmaceuticals announced an agreement with Apricus Biosciences, Inc, granting Ferring global assets and rights, excluding the U.S., related to Apricus Vitaros.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2017 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com